NO2829881T3 - - Google Patents

Info

Publication number
NO2829881T3
NO2829881T3 NO14178981A NO14178981A NO2829881T3 NO 2829881 T3 NO2829881 T3 NO 2829881T3 NO 14178981 A NO14178981 A NO 14178981A NO 14178981 A NO14178981 A NO 14178981A NO 2829881 T3 NO2829881 T3 NO 2829881T3
Authority
NO
Norway
Application number
NO14178981A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2010903140A external-priority patent/AU2010903140A0/en
Application filed filed Critical
Publication of NO2829881T3 publication Critical patent/NO2829881T3/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57419Specifically defined cancers of colon
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NO14178981A 2010-07-14 2011-07-14 NO2829881T3 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2010903140A AU2010903140A0 (en) 2010-07-14 Diagnostic for colorectal cancer
EP11806149.8A EP2593795A4 (fr) 2010-07-14 2011-07-14 Diagnostic en matière de cancer colorectal

Publications (1)

Publication Number Publication Date
NO2829881T3 true NO2829881T3 (fr) 2018-01-20

Family

ID=45468816

Family Applications (1)

Application Number Title Priority Date Filing Date
NO14178981A NO2829881T3 (fr) 2010-07-14 2011-07-14

Country Status (13)

Country Link
US (2) US20130345322A1 (fr)
EP (2) EP2829881B1 (fr)
JP (1) JP6061344B2 (fr)
CN (2) CN105755112B (fr)
AU (1) AU2011279555B2 (fr)
BR (1) BR112013000745B1 (fr)
DK (1) DK2829881T3 (fr)
ES (1) ES2653646T3 (fr)
IN (1) IN2013CN01129A (fr)
NO (1) NO2829881T3 (fr)
PT (1) PT2829881T (fr)
RU (1) RU2013103995A (fr)
WO (1) WO2012006681A1 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011279555B2 (en) * 2010-07-14 2016-10-20 Vision Tech Bio Pty Ltd Diagnostic for colorectal cancer
US9141756B1 (en) 2010-07-20 2015-09-22 University Of Southern California Multi-scale complex systems transdisciplinary analysis of response to therapy
WO2012106556A2 (fr) 2011-02-02 2012-08-09 Amgen Inc. Méthodes et compositions associées à l'inhibition d'igf-1r
JP6298054B2 (ja) 2012-08-09 2018-03-20 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 心不全の診断
GB201218341D0 (en) * 2012-10-12 2012-11-28 Orign Sciences Ltd Diagnostic method
SG11201608053PA (en) * 2014-03-28 2016-10-28 Applied Proteomics Inc Protein biomarker profiles for detecting colorectal tumors
EP3170005B1 (fr) * 2014-07-18 2019-04-10 Sanofi Procédé permettant de prédire le résultat d'un traitement avec de l'aflibercept d'un patient suspecté de souffrir d'un cancer
CN106191215B (zh) * 2015-04-29 2020-03-24 中国科学院上海生命科学研究院 肌肉萎缩相关的蛋白质分子标记Dkk-3的筛选及其应用
AU2016260845B2 (en) * 2015-05-12 2021-01-28 Superlab Far East Limited Methods of determining interferon having direct inhibitory effects on tumors and uses thereof
CN105219844B (zh) * 2015-06-08 2018-12-14 华夏京都医疗投资管理有限公司 一种筛查十一种疾病的基因标志物组合、试剂盒以及疾病风险预测模型
CN105021828B (zh) * 2015-07-20 2017-07-28 上海交通大学医学院附属新华医院 通过检测三期结直肠肿瘤患者血清预测肿瘤患者预后
CN105567846A (zh) * 2016-02-14 2016-05-11 上海交通大学医学院附属仁济医院 检测粪便中细菌dna的试剂盒及其在大肠癌诊断中的应用
JP6984862B2 (ja) * 2017-03-15 2021-12-22 国立大学法人金沢大学 血中ケモカインをマーカーとして用いた大腸癌の検出
CN107164535A (zh) * 2017-07-07 2017-09-15 沈阳宁沪科技有限公司 一种无创高通量甲基化结肠癌诊断、研究和治疗方法
CN110540588B (zh) * 2018-05-28 2022-08-23 香港中文大学 一种基于肿瘤干细胞标志物EpCAM的抗原表位多肽及其应用
CN108957014A (zh) * 2018-09-27 2018-12-07 郑州大学第附属医院 结直肠癌血清标志物、表达评估方法、试剂盒及应用
WO2020086729A1 (fr) * 2018-10-23 2020-04-30 Blackthorn Therapeutics, Inc. Systèmes et procédés de sélection, de diagnostic et de stratification de patients
JP7442967B2 (ja) 2018-11-30 2024-03-05 トヨタ紡織株式会社 センターブラケット
CN109504778B (zh) * 2019-01-11 2021-11-09 复旦大学附属中山医院 一种基于表观修饰的5hmC多分子标志物及结直肠癌早期诊断模型
MX2021010451A (es) * 2019-03-01 2021-12-10 Advanced Marker Discovery S L Firma proteica para la diagnosis de cáncer colorrectal y/o etapa pre cancerosa del mismo.
JP7300660B2 (ja) * 2019-04-03 2023-06-30 京都府公立大学法人 大腸がんの検出方法
JP7032764B2 (ja) * 2019-04-03 2022-03-09 京都府公立大学法人 大腸がんの検出方法
EP3835789A1 (fr) 2019-12-13 2021-06-16 Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts Panel de biomarqueurs pour le diagnostic du cancer colorectal
WO2022130597A1 (fr) * 2020-12-18 2022-06-23 国立大学法人東北大学 Dispositif d'inférence, procédé d'inférence, programme d'inférence, dispositif de génération et système d'inférence
CA3216160A1 (fr) * 2021-04-20 2022-10-27 Trevor Lockett Biomarqueurs pour le cancer colorectal
CA3228665A1 (fr) * 2021-08-11 2023-02-16 Trevor Lockett Procede de detection d'adenome
WO2023128429A1 (fr) * 2021-12-31 2023-07-06 주식회사 이노제닉스 Procédé de dépistage du cancer colorectal et de l'adénome avancé, et son application
WO2023128419A1 (fr) * 2021-12-31 2023-07-06 주식회사 이노제닉스 Procédé de dépistage du cancer colorectal et des polypes colorectaux ou des adénomes avancés et son application
CN114594259B (zh) * 2022-04-22 2022-09-13 北京易科拜德科技有限公司 一种新型的用于结直肠癌预后预测和诊断的模型及其应用
PL441319A1 (pl) * 2022-05-31 2023-12-04 Uniwersytet Medyczny Im. Piastów Śląskich We Wrocławiu Zestaw biomarkerów białkowych i sposób diagnostyki raka jelita grubego in vitro

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925517A (en) 1993-11-12 1999-07-20 The Public Health Research Institute Of The City Of New York, Inc. Detectably labeled dual conformation oligonucleotide probes, assays and kits
US20040157278A1 (en) * 2002-12-13 2004-08-12 Bayer Corporation Detection methods using TIMP 1
US20050014165A1 (en) * 2003-07-18 2005-01-20 California Pacific Medical Center Biomarker panel for colorectal cancer
EP2280286A1 (fr) * 2003-09-15 2011-02-02 Oklahoma Medical Research Foundation Procédé d'utilisation de dosages de cytokine pour diagnostiquer, traiter et évaluer le lupus érythémateux systémique
BRPI0401830A (pt) 2004-05-25 2006-01-17 Bentonit Uniao Nordeste Sa Processo de produção de pós granulados secos
EP2032989B2 (fr) 2006-06-30 2015-10-28 Merck Sharp & Dohme Corp. Biomarqueur igfbp2
US9060961B2 (en) 2006-11-09 2015-06-23 University Of Washington Molecules and methods for treatment and detection of cancer
RU2473555C2 (ru) * 2006-12-19 2013-01-27 ДжинГоу, Инк. Новые способы функционального анализа большого количества экспериментальных данных и групп генов, идентифицированных из указанных данных
WO2008100913A2 (fr) 2007-02-12 2008-08-21 The Johns Hopkins University Détection précoce et pronostic de cancers du côlon
EP2126579A2 (fr) * 2007-02-27 2009-12-02 Sentoclone AB Détection multiple de cellules tumorales utilisant plusieurs agents se fixant à des marqueurs extracellulaires
WO2008116178A2 (fr) * 2007-03-21 2008-09-25 Vanderbilt University Systèmes et procédés pour le diagnostic et le pronostic du cancer colorectal
WO2008138522A1 (fr) * 2007-05-10 2008-11-20 Roche Diagnostics Gmbh Utilisation de timp-1 comme marqueur du cancer colorectal
WO2008144345A2 (fr) * 2007-05-17 2008-11-27 Bristol-Myers Squibb Company Biomarqueurs et procédés pour déterminer la sensibilité de modulateurs de récepteur de facteur de croissance de type 1 semblable à l'insuline
JP2011517765A (ja) * 2007-06-04 2011-06-16 ダイアグノプレックス エセアー 結腸直腸癌のためのバイオマーカの組み合わせ
US20090017463A1 (en) * 2007-07-10 2009-01-15 Vanderbilt University Methods for predicting prostate cancer recurrence
EP2271775A4 (fr) * 2008-04-08 2011-09-07 Nuclea Biomarkers Llc Panel de biomarqueurs pour la prédiction d'un cancer colorectal récurrent
US20100111969A1 (en) * 2008-10-31 2010-05-06 Apogenix Gmbh Il-4 receptor and il-13 as prognostic markers for colon and pancreas tumors
WO2010065567A2 (fr) * 2008-12-01 2010-06-10 Lifespan Extension Llc Procédés et compositions pour modifier la santé, le bien-être et l'espérance de vie
CN102308212A (zh) * 2008-12-04 2012-01-04 加利福尼亚大学董事会 用于确定前列腺癌诊断和预后的材料和方法
WO2010096674A2 (fr) * 2009-02-20 2010-08-26 The Regents Of The University Of California Dosages de biomarqueur a+
US20110177525A1 (en) * 2010-01-19 2011-07-21 Predictive Biosciences, Inc. Antibodies and methods of diagnosing diseases
AU2011279555B2 (en) 2010-07-14 2016-10-20 Vision Tech Bio Pty Ltd Diagnostic for colorectal cancer

Also Published As

Publication number Publication date
WO2012006681A1 (fr) 2012-01-19
EP2829881A3 (fr) 2015-05-13
BR112013000745B1 (pt) 2021-02-02
ES2653646T3 (es) 2018-02-08
EP2829881A2 (fr) 2015-01-28
CN103140760A (zh) 2013-06-05
CN105755112B (zh) 2019-06-07
CN105755112A (zh) 2016-07-13
DK2829881T3 (en) 2017-12-04
BR112013000745A2 (pt) 2016-05-24
US10877039B2 (en) 2020-12-29
EP2593795A1 (fr) 2013-05-22
IN2013CN01129A (fr) 2015-07-31
US20130345322A1 (en) 2013-12-26
CN103140760B (zh) 2016-01-27
JP6061344B2 (ja) 2017-01-18
EP2829881B1 (fr) 2017-08-23
AU2011279555A1 (en) 2013-01-31
EP2593795A4 (fr) 2014-01-22
PT2829881T (pt) 2017-11-29
US20170205414A1 (en) 2017-07-20
JP2013533977A (ja) 2013-08-29
AU2011279555B2 (en) 2016-10-20
RU2013103995A (ru) 2014-08-20

Similar Documents

Publication Publication Date Title
BR112013008959A2 (fr)
BR112012031500A2 (fr)
BR112012024897A2 (fr)
BR112012025307A2 (fr)
BR112012019354A2 (fr)
BR112012002126A2 (fr)
BR112012025482A2 (fr)
BR112013006400A2 (fr)
BR112012031826A2 (fr)
NO2829881T3 (fr)
BR112012025577A2 (fr)
BR112012023249A2 (fr)
BR112012016456A2 (fr)
BR112012018256A2 (fr)
BR112012025308A2 (fr)
BR112012024872A2 (fr)
BR112013010949A2 (fr)
BR112012023265A2 (fr)
BR112013003284A2 (fr)
BR112013002646A2 (fr)
BR112012022788A2 (fr)
BR112012023446A2 (fr)
BR112013006825A2 (fr)
BR112012016895A2 (fr)
BR112013007728A2 (fr)